+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ASTONEALAB ASTONEALAB

Astonea Labs Share Price

₹324.00 +0 (0%)
174.58% Gain from 52W Low

12 Oct, 2026 4:00 PM (IST)

Astonea Labs live price: ₹324.00. It opened at ₹324 vs previous close ₹324; intraday high/low: ₹324/₹324. The 50 & 200 DMA stand at ₹293.50/₹224.80.

Astonea Labs Performance

  • Today's Low
  • ₹324
  • Today's High
  • ₹324
  • 52 Week Low
  • ₹118
  • 52 Week High
  • ₹369
  • Open Price₹324
  • Previous Close₹324
  • Volume2,000
  • 50 DMA₹293.50
  • 100 DMA₹260.20
  • 200 DMA₹224.80

Astonea Labs Chart

Investment Returns

  • Over 1 Month + 12.11%
  • Over 3 Month + 14.67%
  • Over 6 Month + 109.03%
  • Over 1 Year + 103.2%

Smart Investing Starts Here Start SIP with Astonea Labs for Steady Growth!

Invest Now

Astonea Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 75.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 341
  • P/B Ratio
  • 6
  • Average True Range
  • 9.6
  • EPS
  • 4.3
  • Dividend Yield
  • 0
  • MACD Signal
  • 14
  • RSI
  • 55.71
  • MFI
  • 76.4

Latest Stock News Updates

Astonea Labs Ltd - 544409 - Intimation Regarding Change In The Corporate Identification Number (CIN) Of The Company Consequent Upon Alteration Of The Object Clause Of The Memorandum Of Association

Please find enclosed herewith an Intimation regarding change in the Corporate Identification Number (CIN) of the Company consequent upon alteration of the Object Clause of the Memorandum of Association.

Astonea Labs Ltd - 544409 - Incorporation Of Proposed Subsidiary- Longevity Science Private Limited

Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Incorporation of Proposed Subsidiary- Longevity Science Private Limited

Astonea Labs Ltd - 544409 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find enclosed herewith the Certificate under Reg. 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, pertaining to the quarter ended 30.09.2026.

Astonea Labs Financials

Astonea Labs Technicals

EMA & SMA

Current Price
₹324.00
0 (0%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹320.60
  • 50 Day
  • ₹293.50
  • 100 Day
  • ₹260.20
  • 200 Day
  • ₹224.80

Resistance and Support

324 Pivot Speed
  • R3 324.10
  • R2 324.00
  • R1 324.00
  • S1 324.00
  • S2 323.90
  • S3 323.90

Astonea Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-24 Audited Results & A.G.M.
2026-05-30 Audited Results
2026-02-27 Notice of EGM & Others Inter-alia, to consider 1. Proposal for variation in the objects of the IPO. 2. Adoption of the new set of AOA of company. 3. Relocation of the Registered Office. 4. Other business matters.
2025-12-03 A.G.M. Inter alia, 1. To consider and approve the Notice convening the Annual General Meeting (AGM) of the Company for the financial year 2024-25.
2025-11-10 Half Yearly Results

Astonea Labs Shareholding Pattern

72.44%
27.57%
0%

About Astonea Labs

Astonea Labs is a pharmaceutical and cosmetic contract manufacturer It provides third-party manufacturing, formulation development, and own-brand products for domestic and international markets. (Source : Company Website) View More
  • NSE Symbol
  • ASTONEALAB
  • BSE Symbol
  • 544409
  • ISIN
  • INE0TG901011

Similar Stocks to Astonea Labs

Astonea Labs FAQs

Astonea Labs share price is ₹324 As on 14 October, 2026 | 03:27

The Market Cap of Astonea Labs is ₹340.6 Cr As on 14 October, 2026 | 03:27

The P/E ratio of Astonea Labs is 75.4 As on 14 October, 2026 | 03:27

The PB ratio of Astonea Labs is 6 As on 14 October, 2026 | 03:27

The 52 week High & Low of Astonea Labs is ₹369/₹118 respectively As on 14 October, 2026 | 03:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23